Evidence map›Paper›PMID 23277357›Full record

ArticleThe Journal of biological chemistry2013

Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.

Jason J Northey, Zhifeng Dong, Elaine Ngan, Andrew Kaplan, W Rod Hardy, Tony Pawson, Peter M Siegel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Emerging roles for LPP in metastatic cancer progression.Journal of cell communication and signaling · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Targeting metastasis.Nature reviews. Cancer · 2016
    Review
  11. Article
  12. High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jason J NortheyGoodman Cancer Research Centre, McGill University, Montréal, Québec H3A 1A3, Canada.
Zhifeng Dong
Elaine Ngan
Andrew Kaplan
W Rod Hardy
Tony Pawson
Peter M Siegel
McGill University · CALunenfeld-Tanenbaum Research Institute · CAUniversity of Massachusetts Chan Medical School · US

Funding

Worldwide Cancer Research 11-0204
6 · The paper itself

Abstract

The ErbB2 and TGFβ signaling pathways cooperate to promote the migratory, invasive, and metastatic behavior of breast cancer cells. We previously demonstrated that ShcA is necessary for these synergistic interactions. Through a structure/function approach, we now show that the phosphotyrosine-binding, but not the Src homology 2, domain of ShcA is required for TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. We further demonstrate that the tyrosine phosphorylation sites within ShcA (Tyr(239)/Tyr(240) and Tyr(313)) transduce distinct and non-redundant signals that promote these TGFβ-mediated effects. We demonstrate that Grb2 is required specifically downstream of Tyr(313), whereas the Tyr(239)/Tyr(240) phosphorylation sites require the Crk adaptor proteins to augment TGFβ-induced migration and invasion. Furthermore, ShcA Tyr(313) phosphorylation enhances tumor cell survival, and ShcA Tyr(239)/Tyr(240) signaling promotes endothelial cell recruitment into ErbB2-expressing breast tumors in vivo, whereas all three ShcA tyrosine residues are required for efficient breast cancer metastasis to the lungs. Our data uncover a novel ShcA-dependent signaling axis downstream of TGFβ and ErbB2 that requires both the Grb2 and Crk adaptor proteins to increase the migratory and invasive properties of breast cancer cells. In addition, signaling downstream of specific ShcA tyrosine residues facilitates the survival, vascularization, and metastatic spread of breast tumors.

Indexed as

Amino Acid MotifsAnimalsBreast NeoplasmsCell MovementCell SurvivalErb-b2 Receptor Tyrosine KinasesFemaleHumansLung NeoplasmsMammary Neoplasms, AnimalMiceNeoplasm InvasivenessNeoplasm MetastasisPhosphorylationPhosphotyrosineRNA, Small InterferingERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesPhosphotyrosineRNA, Small InterferingSHC1 protein, humanShc Signaling Adaptor ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1Transforming Growth Factor beta1

Identifiers

PMID23277357
PMCPMC3576125
OpenAlexW2089373296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.